Clinical Trial Update: Study of MT027 in Patients with Brain, Meninges, and Spinal Cord Metastatic Solid Tumors [Phase 1]

View source ↗

Summary

Phase 1 clinical trial update for MT027 in patients with brain, meninges, and spinal cord metastatic solid tumors; study status is not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Brain Cancer
• Brain Tumor
• Central Nervous System Tumor

Drugs mentioned

• MT027

Snippet

Sponsor: Suzhou Maximum Bio-tech Co., Ltd. | Conditions: Brain (Nervous System) Cancers, Brain and Central Nervous System Tumors | Phase 1 | Status: NOT_YET_RECRUITING